Therapy without compromise
Tailor a DBS system specific to your workflow and each of your patients’ needs. With four MR-Conditional* implantable pulse generators (IPGs), the most therapy options and Image Guided DBS, Boston Scientific’s Deep Brain Stimulation System enables you to personalise DBS therapy as unique as each one of your patients.
To get answers to your questions and additional information, contact a DBS sales representative.
Deep Brain Stimulation (DBS) is a well-established, safe, and effective treatment that helps improve day-to-day experiences and quality of life for patients whose symptoms are no longer controlled by medication.
The DBS device sends signals to your brain to help control the symptoms of movement disorders. The implanting surgeon will place one or two insulated wires called ’leads’ (1) in the brain.
The leads are then connected to the stimulator (2) which is placed under the skin in the chest. When the stimulator is turned on, it produces mild electrical impulses (3) that stimulate a specific target within the brain.
The stimulation may help regulate the incorrect signaling in the brain, improving some of the symptoms of movement disorders.
Easily customise therapy to match each patient’s needs with the Vercise Genus DBS system.
4 thin, contoured ImageReady MR-Conditional rechargeable and non-rechargeable IPGs.
The most therapy options including Semi-bipolar and Anodic stimulation.
Personalise therapy with Image Guided Programming.
See stimulation to personalize therapy in each patient’s specific anatomy. Image Guided Programming makes delivering directional stimulation easier and more efficient, with a 56%¹ reduction in programming time.**
Vercise Neural Navigator 5 Software makes it easier and more efficient to personalise your patients’ DBS journey.
*The Vercise Genus™ DBS System, Vercise Genus Mixed System with M8 Adapter, Vercise Gevia™ DBS System, and Vercise™ DBS Lead-only system (before Stimulator is implanted) provide safe access to full-body MRI scans when used with specific components and the patient is exposed to the MRI environment under specific conditions defined in the supplemental manual ImageReady™ MRI Guidelines for Boston Scientific DBS Systems.
**Image Guided programming in PD patients enables a reduction in programming time compared with standard clinical based programming (p=39).
Lange F, Et al. Reduced Programming Time and Strong Symptom Control Even in Chronic Course Through Imaging-Based DBS Programming. Front Neurol. 2021 Nov 8;12:785529. N=10.
CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.
